跳至主要内容
临床试验/NCT01343862
NCT01343862Unknown2 期

The Effect of Single Dose D-Cycloserine on Cognitive Outcome in Moderate TBI Patients

Hadassah Medical Organization3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
100
试验地点
3
主要终点
A battery of neuropsychological tests at 3 and 6 months post-injury

研究概览

简要总结

In this study of patients with moderate traumatic brain injury with frontal brain contusions patients will be randomized to treatment with a single dose of either D-cycloserine or placebo given 48-72 hours after injury.

Patients will undergo intensive neurocognitive testing at 3 and 6 months after injury to assess whether treatment with a single dose of D-cycloserine improves cognitive outcome after moderate brain injury.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • TBI diagnosed by history and/or clinical examination with presenting GCS between 9 -13
  • Age between 18 and 55 years
  • Frontal cerebral contusion(s) located in the frontal cortex and/or traumatic subarachnoid hemorrhage on initial CT scan
  • Prior to randomization, patient is able to swallow an orally administered tablet or has a nasogastric tube in place per medical indication
  • Informed consent will be obtained in those patients who have regained full cognition and judgment following their injury and are fully capable of understanding the study protocol, its risks and potential benefits, and of giving informed consent for participation in the study. In any patient that has not regained full cognition and judgment, only a temporary legal guardian (apotropos) appointed by an authorized judge that has been given a full explanation of the study protocol, its risks and potential benefits will be authorized to give informed consent for participation in the study.

排除标准

  • Penetrating brain injury
  • Any traumatic intracranial lesion requiring neurosurgical intervention prior to time of randomization
  • Other severe systemic injuries leading to severe hypotension, hemodynamic instability following initial resuscitation (SBP < 90 mmHg), severe hypoxia.
  • Intubation lasting > 12 hours prior to randomization
  • Suspected or confirmed pregnancy or lactating women
  • Any spinal cord injury
  • Known or CT scan evidence of previous major cerebral damage
  • Any severe concomitant condition (malignancy, renal, hepatic, or major psychiatric disorder)
  • Known treatment with another investigational drug within 30 days of injury
  • Known contraindication to enteral administration of drug prior to randomization (GI bleed, ileus, severe abdominal injury, etc.)
  • Known contraindication to placement of a nasogastric tube in patients unable to swallow an orally administered tablet

研究组 & 干预措施

D- Cycloserine

Experimental

干预措施: D-cycloserine (Drug)

sugar pill

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

A battery of neuropsychological tests at 3 and 6 months post-injury

时间窗: 3 and 6 months post-injury

* Symbol Digit Modalities Test (Smith 1973) * Trail Making Test (TMT) (Reitan, Hom et al. 1988) * Digit Span (DS) from the WAIS-III * Rey Auditory Verbal Learning Test (RAVLT) (Rey 1955; Lezak 2004) * Wisconsin Card Sorting Test (WCST) (Psychological Assessment Resources. Computerised Wisconsin Card Sort Task Version 4 (WCST). Psychological Assessment Resources; 2003). * Test of Variables of Attention (TOVA) (Test of Variables of Attention: Clinical Manual. Los Alamitos: The TOVA Company). * Behavioral Assessment of the Dysexecutive Syndrome (BADS) (Erez, Rothschild et al. 2009)

次要结局

  • Glasgow Outcome Score - Extended (GOS-E)(3 and 6 months post injury)

研究者

申办方类型
Other

研究点 (3)

Loading locations...

相似试验